MIANSERIN TREATMENT OF PATIENTS WITH PSYCHOSIS INDUCED BY ANTIPARKINSONIAN DRUGS

Citation
K. Ikeguchi et A. Kuroda, MIANSERIN TREATMENT OF PATIENTS WITH PSYCHOSIS INDUCED BY ANTIPARKINSONIAN DRUGS, European archives of psychiatry and clinical neuroscience, 244(6), 1995, pp. 320-324
Citations number
39
Categorie Soggetti
Psychiatry,Neurosciences
ISSN journal
09401334
Volume
244
Issue
6
Year of publication
1995
Pages
320 - 324
Database
ISI
SICI code
0940-1334(1995)244:6<320:MTOPWP>2.0.ZU;2-#
Abstract
We evaluated the effects of mianserin, a relatively selective 5-HT2 re ceptor antagonist, on symptoms related to drug-induced psychosis in pa tients with Parkinson's disease (PD). A total of 12 patients with PD w ho had developed drug-induced psychosis showed delirium (DSM-III-R cri teria; n = 10) and pure visual hallucinations (n = 2). The antiparkins onian drugs involved in the drug-induced psychosis were L-DOPA/carbido pa, bromocriptine, trihexyphenidyl, and amantadine. They received mian serin (mean 36.7 mg, range 20-60 mg) given orally for 8 weeks. Complet e relief or marked improvement in psychotic symptoms was noted in 8 pa tients, moderate improvement in 2 patients, and no effect in 2 patient s. The parkinsonian disability also decreased slightly in 8 patients. These results suggest that serotonin antagonism at 5-HT, receptors may not only play an important role in the treatment of drug-induced psyc hosis in PD, but may also ameliorate the symptoms of parkinsonism.